{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:18:38Z","timestamp":1780319918258,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Harvard Catalyst Faculty Fellowship Program-Harvard Medical School"},{"name":"Vincent Memorial Research Funds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12958-018-0364-8","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T23:54:35Z","timestamp":1525996475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma"],"prefix":"10.1186","volume":"16","author":[{"given":"Eden R.","family":"Cardozo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatte E.","family":"Karmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah W.","family":"Gatune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo R.","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron K.","family":"Styer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"364_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"364_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/AOG.0b013e318299a6cf","volume":"122","author":"JD Wright","year":"2013","unstructured":"Wright JD, Herzog TJ, Tsui J, Ananth CV, Lewin SN, Lu YS, Neugut AI, Hershman DL. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol. 2013;122:233\u201341.","journal-title":"Obstet Gynecol"},{"key":"364_CR3","doi-asserted-by":"publisher","first-page":"211 e211","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206:211 e211\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"364_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1055\/s-0030-1251476","volume":"28","author":"N Chegini","year":"2010","unstructured":"Chegini N. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med. 2010;28:180\u2013203.","journal-title":"Semin Reprod Med"},{"key":"364_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1042\/BST0350661","volume":"35","author":"J Gauldie","year":"2007","unstructured":"Gauldie J, Bonniaud P, Sime P, Ask K, Kolb M. TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans. 2007;35:661\u20134.","journal-title":"Biochem Soc Trans"},{"key":"364_CR6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/humrep\/deh698","volume":"20","author":"AA Arslan","year":"2005","unstructured":"Arslan AA, Gold LI, Mittal K, Suen TC, Belitskaya-Levy I, Tang MS, Toniolo P. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod. 2005;20:852\u201363.","journal-title":"Hum Reprod"},{"key":"364_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1933719115584449","volume":"23","author":"Q Yang","year":"2016","unstructured":"Yang Q, Mas A, Diamond MP, Al-Hendy A. The mechanism and function of epigenetics in uterine leiomyoma development. Reprod Sci. 2016;23:163\u201375.","journal-title":"Reprod Sci"},{"key":"364_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/humupd\/dmu017","volume":"20","author":"AE Karmon","year":"2014","unstructured":"Karmon AE, Cardozo ER, Rueda BR, Styer AK. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention? Hum Reprod Update. 2014;20:760\u201387.","journal-title":"Hum Reprod Update"},{"key":"364_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"364_CR10","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1073\/pnas.0707594105","volume":"105","author":"RF Place","year":"2008","unstructured":"Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A. 2008;105:1608\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"364_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.1178178","volume":"327","author":"RE Lanford","year":"2010","unstructured":"Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010;327:198\u2013201.","journal-title":"Science"},{"key":"364_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1530\/REP-11-0240","volume":"143","author":"WB Nothnick","year":"2012","unstructured":"Nothnick WB. The role of micro-RNAs in the female reproductive tract. Reproduction. 2012;143:559\u201376.","journal-title":"Reproduction"},{"key":"364_CR13","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"364_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1210\/me.2012-1075","volume":"26","author":"TD Chuang","year":"2012","unstructured":"Chuang TD, Luo X, Panda H, Chegini N. miR-93\/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol. 2012;26:1028\u201342.","journal-title":"Mol Endocrinol"},{"key":"364_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1530\/ERC-12-0007","volume":"19","author":"TD Chuang","year":"2012","unstructured":"Chuang TD, Panda H, Luo X, Chegini N. miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. Endocr Relat Cancer. 2012;19:541\u201356.","journal-title":"Endocr Relat Cancer"},{"key":"364_CR16","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.fertnstert.2007.05.074","volume":"89","author":"EE Marsh","year":"2008","unstructured":"Marsh EE, Lin Z, Yin P, Milad M, Chakravarti D, Bulun SE. Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. Fertil Steril. 2008;89:1771\u20136.","journal-title":"Fertil Steril"},{"key":"364_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012362","volume":"5","author":"J Zavadil","year":"2010","unstructured":"Zavadil J, Ye H, Liu Z, Wu J, Lee P, Hernando E, Soteropoulos P, Toruner GA, Wei JJ. Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas. PLoS One. 2010;5:e12362.","journal-title":"PLoS One"},{"key":"364_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/gcc.20415","volume":"46","author":"T Wang","year":"2007","unstructured":"Wang T, Zhang X, Obijuru L, Laser J, Aris V, Lee P, Mittal K, Soteropoulos P, Wei JJ. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer. 2007;46:336\u201347.","journal-title":"Genes Chromosomes Cancer"},{"key":"364_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078115","volume":"8","author":"JC Akers","year":"2013","unstructured":"Akers JC, Ramakrishnan V, Kim R, Skog J, Nakano I, Pingle S, Kalinina J, Hua W, Kesari S, Mao Y, et al. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS One. 2013;8:e78115.","journal-title":"PLoS One"},{"key":"364_CR20","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1053\/j.gastro.2009.02.002","volume":"136","author":"T Kan","year":"2009","unstructured":"Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y, Agarwal R, Paun BC, Jin Z, Olaru AV, et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology. 2009;136:1689\u2013700.","journal-title":"Gastroenterology"},{"key":"364_CR21","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","volume":"26","author":"ML Si","year":"2007","unstructured":"Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene. 2007;26:2799\u2013803.","journal-title":"Oncogene"},{"key":"364_CR22","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1038\/onc.2013.492","volume":"33","author":"X Sun","year":"2014","unstructured":"Sun X, Jiao X, Pestell TG, Fan C, Qin S, Mirabelli E, Ren H, Pestell RG. MicroRNAs and cancer stem cells: the sword and the shield. Oncogene. 2014;33:4967\u201377.","journal-title":"Oncogene"},{"key":"364_CR23","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1007\/s00380-016-0808-z","volume":"31","author":"X He","year":"2016","unstructured":"He X, Zhang K, Gao X, Li L, Tan H, Chen J, Zhou Y. Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit. Heart Vessel. 2016;31:1696\u2013708.","journal-title":"Heart Vessel"},{"key":"364_CR24","doi-asserted-by":"publisher","first-page":"27209","DOI":"10.1038\/srep27209","volume":"6","author":"MF Hennino","year":"2016","unstructured":"Hennino MF, Buob D, Van der Hauwaert C, Gnemmi V, Jomaa Z, Pottier N, Savary G, Drumez E, Noel C, Cauffiez C, Glowacki F. miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy. Sci Rep. 2016;6:27209.","journal-title":"Sci Rep"},{"key":"364_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154942","volume":"11","author":"OS Kwon","year":"2016","unstructured":"Kwon OS, Kim KT, Lee E, Kim M, Choi SH, Li H, Fornace AJ Jr, Cho JH, Lee YS, Lee JS, et al. Induction of MiR-21 by stereotactic body radiotherapy contributes to the pulmonary fibrotic response. PLoS One. 2016;11:e0154942.","journal-title":"PLoS One"},{"key":"364_CR26","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1084\/jem.20100035","volume":"207","author":"G Liu","year":"2010","unstructured":"Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 2010;207:1589\u201397.","journal-title":"J Exp Med"},{"key":"364_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fphys.2012.00049","volume":"3","author":"A Noetel","year":"2012","unstructured":"Noetel A, Kwiecinski M, Elfimova N, Huang J, Odenthal M. microRNA are central players in anti- and Profibrotic gene regulation during liver fibrosis. Front Physiol. 2012;3:49.","journal-title":"Front Physiol"},{"key":"364_CR28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.fertnstert.2016.05.001","volume":"106","author":"EE Marsh","year":"2016","unstructured":"Marsh EE, Steinberg ML, Parker JB, Wu J, Chakravarti D, Bulun SE. Decreased expression of microRNA-29 family in leiomyoma contributes to increased major fibrillar collagen production. Fertil Steril. 2016;106:766\u201372.","journal-title":"Fertil Steril"},{"key":"364_CR29","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.fertnstert.2009.01.081","volume":"93","author":"DS Joseph","year":"2010","unstructured":"Joseph DS, Malik M, Nurudeen S, Catherino WH. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3. Fertil Steril. 2010;93:1500\u20138.","journal-title":"Fertil Steril"},{"key":"364_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.fertnstert.2014.03.042","volume":"102","author":"G Levy","year":"2014","unstructured":"Levy G, Malik M, Britten J, Gilden M, Segars J, Catherino WH. Liarozole inhibits transforming growth factor-beta3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures. Fertil Steril. 2014;102:272\u201381. e272","journal-title":"Fertil Steril"},{"key":"364_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2265.2008.03207.x","volume":"69","author":"M Malik","year":"2008","unstructured":"Malik M, Webb J, Catherino WH. Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells. Clin Endocrinol. 2008;69:462\u201370.","journal-title":"Clin Endocrinol"},{"key":"364_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"364_CR33","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1158\/1078-0432.CCR-14-1647","volume":"20","author":"JW Groeneweg","year":"2014","unstructured":"Groeneweg JW, Hernandez SF, Byron VF, DiGloria CM, Lopez H, Scialabba V, Kim M, Zhang L, Borger DR, Tambouret R, et al. Dual HER2 targeting impedes growth of HER2 gene-amplified uterine serous carcinoma xenografts. Clin Cancer Res. 2014;20:6517\u201328.","journal-title":"Clin Cancer Res"},{"key":"364_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1582-4934.2007.00207.x","volume":"12","author":"Q Pan","year":"2008","unstructured":"Pan Q, Luo X, Chegini N. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J Cell Mol Med. 2008;12:227\u201340.","journal-title":"J Cell Mol Med"},{"key":"364_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/molehr\/gap093","volume":"16","author":"Q Pan","year":"2010","unstructured":"Pan Q, Luo X, Chegini N. microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Mol Hum Reprod. 2010;16:215\u201327.","journal-title":"Mol Hum Reprod"},{"key":"364_CR36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/molehr\/gas045","volume":"18","author":"Notice Of Retraction","year":"2012","unstructured":"Notice Of Retraction. 'MicroRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells' by Qun Pan, Xiaoping Luo and Nasser Chegini, molecular human reproduction (MHR) 16: 215-227 (2010). Doi:10.1093\/molehr\/gap093. Mol Hum Reprod. 2012;18:613.","journal-title":"Mol Hum Reprod"},{"key":"364_CR37","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1111\/jcmm.12621","volume":"19","author":"Retracted","year":"2015","unstructured":"Retracted. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J Cell Mol Med. 2015;19:2512.","journal-title":"J Cell Mol Med"},{"key":"364_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","volume":"195","author":"PC Leppert","year":"2006","unstructured":"Leppert PC, Catherino WH, Segars JH. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol. 2006;195:415\u201320.","journal-title":"Am J Obstet Gynecol"},{"key":"364_CR39","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1177\/1933719109343310","volume":"16","author":"JM Norian","year":"2009","unstructured":"Norian JM, Malik M, Parker CY, Joseph D, Leppert PC, Segars JH, Catherino WH. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod Sci. 2009;16:1153\u201364.","journal-title":"Reprod Sci"},{"key":"364_CR40","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1158\/1078-0432.CCR-06-1811","volume":"13","author":"NJ Laping","year":"2007","unstructured":"Laping NJ, Everitt JI, Frazier KS, Burgert M, Portis MJ, Cadacio C, Gold LI, Walker CL. Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats. Clin Cancer Res. 2007;13:3087\u201399.","journal-title":"Clin Cancer Res"},{"key":"364_CR41","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1210\/endo.130.6.1375903","volume":"130","author":"SK Das","year":"1992","unstructured":"Das SK, Flanders KC, Andrews GK, Dey SK. Expression of transforming growth factor-beta isoforms (beta 2 and beta 3) in the mouse uterus: analysis of the periimplantation period and effects of ovarian steroids. Endocrinology. 1992;130:3459\u201366.","journal-title":"Endocrinology"},{"key":"364_CR42","doi-asserted-by":"publisher","first-page":"E754","DOI":"10.1210\/jc.2010-2131","volume":"96","author":"SK Halder","year":"2011","unstructured":"Halder SK, Goodwin JS, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab. 2011;96:E754\u201362.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-018-0364-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-018-0364-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-018-0364-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T23:18:09Z","timestamp":1557530289000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-018-0364-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["364"],"URL":"https:\/\/doi.org\/10.1186\/s12958-018-0364-8","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,11]]},"assertion":[{"value":"12 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Partners Healthcare Human Research Committee \/Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"46"}}